Takeda’s TAK-003 dengue vaccine candidate succeeds in phase 3 efficacy trial

Image: Takeda’s dengue vaccine candidate meets primary endpoint in pivotal phase 3 efficacy trial. Photo: courtesy of David Parnes Photography.